Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mayumi Nakagawa

Concepts (204)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

The timeline below shows the dates (blue tick marks) of publications associated with Mayumi Nakagawa's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Mayumi Nakagawa has written about over time.
Oncogene Proteins, Viral, 11 publications between 2002 and 2011, average publication date March 2007. Repressor Proteins, 9 publications between 2002 and 2011, average publication date April 2007. Immunity, Cellular, 4 publications between 2002 and 2013, average publication date February 2009. Epitopes, T-Lymphocyte, 7 publications between 2005 and 2018, average publication date May 2009. Epitopes, 2 publications between 2004 and 2015, average publication date January 2010. CD8-Positive T-Lymphocytes, 6 publications between 2005 and 2018, average publication date March 2010. Papillomaviridae, 7 publications between 2002 and 2019, average publication date October 2010. T-Lymphocytes, 6 publications between 2004 and 2021, average publication date June 2011. Papillomavirus Infections, 14 publications between 2002 and 2019, average publication date March 2012. Human papillomavirus 16, 11 publications between 2007 and 2021, average publication date March 2013. Cervical Intraepithelial Neoplasia, 2 publications between 2011 and 2015, average publication date June 2013. Candida, 4 publications between 2010 and 2018, average publication date March 2014. Langerhans Cells, 3 publications between 2013 and 2018, average publication date April 2015. Uterine Cervical Neoplasms, 8 publications between 2006 and 2021, average publication date September 2015. Cancer Vaccines, 3 publications between 2008 and 2021, average publication date July 2016. Cervix Uteri, 3 publications between 2010 and 2021, average publication date December 2016. Papillomavirus Vaccines, 7 publications between 2013 and 2021, average publication date June 2017. Lymphocytes, Tumor-Infiltrating, 1 publications between 2021 and 2021, average publication date September 2021.

To see the data from this visualization as text, click here.
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description